C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2002
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1149104B1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
12/11/2002	EP1100805B1 Medicine nitrate salts
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0793498B1 Bicyclic heterocyclic compounds for the treatment of impotence
12/11/2002	EP0788511B1 Cyclic hexapeptides having antibiotic activity
12/11/2002	EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002	CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases
12/11/2002	CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys
12/11/2002	CN1384746A 单位剂量形式 Unit dosage forms
12/11/2002	CN1384738A Transdermal drug delivery devices
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/10/2002	US6492555 Reaction of a carbamate with either a (s)-secondary alcohol or (s)-epoxide or (s)-ester; bactericides
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1
12/10/2002	US6492377 Imidazotriazolopyrimidines with adenosine-antagonistic activity
12/10/2002	US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002	US6492364 Triazolo and derivatives as chemokine inhibitors
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6492347 Treatment and/or prophylaxis of infection caused by protozoan parasite by administering compound to inhibit purine nucleoside hydrolase, purine nucleoside phosphorylase, and/or purine phosphoribosyl transferase
12/10/2002	US6492100 Silver halide color photographic lightsensitive material and compound used therein
12/10/2002	US6491749 Fluorescent dyes having good fastness to heat and to light
12/06/2002	WO2001096344A1 Novel expanded porphyrins and process for the synthesis thereof
12/05/2002	WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002	WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002	WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002	WO2002096908A1 Antibacterial agents
12/05/2002	WO2002096905A1 Thiazole compounds useful as inhibitors of protein kinases
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002096417A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
12/05/2002	WO2002096366A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
12/05/2002	WO2002096318A2 Method for treating glaucoma v
12/05/2002	WO2002083675A3 Inhibitors of akt activity
12/05/2002	WO2002062798A3 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
12/05/2002	US20020183518 Use for treatment of human and animal disorders, for purification of proteins or glycoproteins, and in diagnosis
12/05/2002	US20020183514 Useful in the treatment and control of solid tumors
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183470 Polymerization of aromatic monomers using derivatives of hematin
12/05/2002	US20020183375 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	US20020183327 For use as analgesics
12/05/2002	US20020183326 1,2,4-triazolo[4,3-B]pyrido[3,2-D]pyridazine derivatives and pharmaceutical compositions containing them
12/05/2002	US20020183320 For use as analgesics
12/05/2002	US20020183319 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
12/05/2002	US20020183311 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
12/05/2002	US20020183307 For therapy of hyperlipidemic condition
12/05/2002	US20020178516 Warp-free pigment compositions comprising diaryldiketoprrolo[3,4-c]pyrroles
12/05/2002	CA2448570A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
12/05/2002	CA2448562A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
12/05/2002	CA2448317A1 Method for treating glaucoma v
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2446697A1 Antibacterial agents
12/04/2002	EP1262966A2 Optical recording medium and novel azaporphyrin compound
12/04/2002	EP1262477A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
12/04/2002	EP1261611A2 Inhibitors of hepatitis c virus ns3 protease
12/04/2002	EP1261610A2 Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
12/04/2002	EP1261609A1 Triazolotriazinones and the use thereof
12/04/2002	EP1261607A1 2,4-disubstituted thiazolyl derivatives
12/04/2002	EP1261356A2 Farnesyl protein transferase inhibitor combinations with platinum compounds
12/04/2002	EP1261346A1 Modulation of cardiovascular injury
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	EP1152763B1 Use of desoxypeganine for the treatment of drug dependence
12/04/2002	EP1111993A4 Fused-benzene derivatives useful as herbicides
12/04/2002	EP0800390B1 Cyclopropylpyrroloindole-oligopeptide anticancer agents
12/04/2002	EP0742218B1 Pyrrolopyridazine derivative
12/04/2002	CN1382687A Process for directly synthesizing pyrimidine, 1,3,5-triazine, phthalocyanine and polynitrile from nitrile
12/03/2002	US6489491 Synthesis of compounds useful in the manufacture of ketorolac
12/03/2002	US6489473 Pyrroloazepine derivatives
12/03/2002	US6489374 Organonitrogen compounds that yield amines, imines or amidines when exposed to visible or ultraviolet radiation; polymerization catalysts used in one-pot systems having storage stability
12/03/2002	US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002	US6489331 Remedies for diabetes
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides
12/03/2002	CA2263500C Malonate derivatives useful as intermediates for producing isoxazolidinadione hypoglycemic agents
12/03/2002	CA2099782C Optically active 5h-pyrrolo[3,4-b] pyrazine, preparation thereof and pharmaceutical compositions contaning same
12/03/2002	CA2080705C Substituted pyrimidines
11/2002
11/28/2002	WO2002094834A1 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094832A1 New benzylaminopyrimidines
11/28/2002	WO2002094831A1 Novel pyridylmethylaminopyrimidines
11/28/2002	WO2002094830A2 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
11/28/2002	WO2002094826A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002	WO2002094822A1 Uronium and immonium salts for peptide coupling
11/28/2002	WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
11/28/2002	WO2002094761A1 Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters
11/28/2002	WO2002094236A1 Delivery of antipsychotics through an inhalation route
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents
11/28/2002	WO2002094020A1 Use of triazolopyrimidine derivatives as microbicides in the protection of materials
11/28/2002	US20020177707 Aminoaryl oxazolidinone n-oxides
11/28/2002	US20020177705 Novel substituted calix (4) pyrroles and process for the synthesis of calix (4) pyrroles over molecular sieve catalysts
11/28/2002	US20020177704 Nitroimidazole substituted porphyrin complex
11/28/2002	US20020177609 Fatty alcohol drug conjugates
11/28/2002	US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002	US20020177599 Cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) inhibitors; 2-(5-Acetyl-2-butoxy-3-pyridinyl)-7-ethyl-5-methylimidazo(5,1 -f)(1,2,4)triazin-4(3H)-one for example
11/28/2002	US20020177596 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist

1 ... 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 ... 573